谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Clinical effectiveness and safety of teriflunomide for patients treated at least 48 months in the Swedish post-market surveillance study "Immunomodulation and Multiple Sclerosis Epidemiology 4" (IMSE 4)

V. Rosengren,E. Ekstrom,L. Forsberg,S. Kagstrom,J. Hillert,P. Nilsson,C. Dahle,A. Svenningsson,J. Lycke,A. -M. Landtblom,J. Burman,C. Martin,P. Sundstrom,M. Gunnarsson,F. Piehl,T. Olsson

MULTIPLE SCLEROSIS JOURNAL（2021）

引用 0|浏览19
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要